Skip Navigation
Skip to contents

KSC 2018

프로그램

Home > Program > 프로그램
[KSoLA 1] Apr. 15 (Fri.) 16:45-17:30 Rm.203
Debate: Are Big-data Studies Over-rated?
Chairperson(s) 김명아, 이상학
Panel 김규리, 진흥용
16:45-17:00 No, It has Big Advantages & Can Almost Replace RCTs 김경민 / 연세의대
17:00-17:15 Yes, Drawbaks are Clear & It Cannot Replace RCTs 원호연 / 중앙의대
17:15-17:30 Discussion
[KSoLA 2] Apr. 16 (Sat.) 08:00-09:40 Rm.203
Current Concepts in Pathophysiology of Atherosclerosis
Chairperson(s) 박경수, 최동훈
Panel 박성하, 황지원
08:00-08:15 Role of Adipose Tissue in Atherosclerosis 최성희 / 서울의대
08:15-08:30 Clonality and Plasticity of Vascular Smooth Muscle Cells 허경선 / 충남대
08:30-08:45 Understanding Results of Single Cell Sequencing 김용숙 / 전남의대
08:45-09:00 New Paradigm for Atherosclerosis; Brain Neurobiology is Linked with Plaque Inflammation 김진원 / 고려의대
09:00-09:30 Discussion
[KSoLA 3] Apr. 16 (Sat.) 09:50-11:30 Rm.203
Secret of Development of New Drugs in Atherosclerosis
Chairperson(s) 장학철, 김재범
Panel 강현재, 박영미, 이승준
09:50-10:10 Know-how of Target Discovery (with Innovative Target Discovery Platform for Metabolic Diseases, iClue-TDMD) 최철수 / 가천의대
10:10-10:30 Comparing Platforms: siRNA, ASO, Ab, and Compound for the Treatment of Dyslipidemia 박정숙 / 충남대
10:30-10:50 Which Target would Survive? Metabolism, Inflammation, or Aging? 조경아 / 전남의대
10:50-11:20 Discussion
[KSoLA 4] Apr. 16 (Sat.) 15:00-16:30 Rm.203
Lifestyle Factors in COVID-19 Pandemic
Chairperson(s) 박중열, 한성림
Panel 김대중, 임정현, 전성완
15:00-15:20 COVID-19 & Changes in Korean Consumers' Dietary Attitude and Behavior 윤지현 / 서울대
15:20-15:40 Obesity as a Risk Factor for COVID-19: Is Physical Exercise the Answer? 곽이섭 / 동아대
15:40-16:00 Updated Dietary Guidelines to Promote Cardiovascular Health 송수진 / 한남대
16:00-16:30 Discussion
[KSoLA 5] Apr. 16 (Sat.) 16:40-18:10 Rm.203
New Korean Lipid Guidelines Now
Chairperson(s) 김치정, 김재택
Panel 김철식, 최성훈
16:40-17:00 How Can We Assess CV Risk for Korean People for Differential Tx? 이찬주 / 연세의대
17:00-17:20 Which Target LDL-C for Very High/High Risk Groups? 김상현 / 서울의대
17:20-17:40 What Risk Grading is Best for DM Patients for Differential Lipid Lowering Therapy? 김경수 / 차의대
17:40-18:10 Discussion